N
VIR icon

Natixis’s Vir Biotechnology VIR Stock Holding History

Natixis’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,043
Closed -$290K – 1360
2022
Q3 		$290K Hold
15,043
– – ﹤0.01% 946
2022
Q2 		$383K Sell
15,043
-97,616
-87% -$2.28M ﹤0.01% 969
2022
Q1 		$2.9M Buy
112,659
+30,209
+37% +$896K 0.01% 662
2021
Q4 		$3.45M Sell
82,450
-23,593
-22% -$924K 0.01% 639
2021
Q3 		$4.62M Buy
+106,043
New +$4.59M 0.02% 565
2021
Q2 		– Sell
-173,110
Closed -$8.88M – 1083
2021
Q1 		$8.88M Sell
173,110
-9,602
-5% -$517K 0.03% 400
2020
Q4 		$4.89M Buy
+182,712
New +$5.94M 0.02% 516

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return